Abstract
Purpose To identify physical activity barriers and facilitators experienced by people with systemic sclerosis (SSc; scleroderma).
Materials and Methods We conducted nominal group technique sessions with SSc patients who shared barriers to physical activities, barrier-specific facilitators, and general facilitators. Participants rated importance of barriers and likelihood of using facilitators from 0-10, and indicated whether they had tried facilitators. Barriers and facilitators across sessions were subsequently merged to eliminate overlap; edited based on feedback from investigators, patient advisors, and clinicians; and categorized.
Results We conducted nine sessions (n=41 total participants) and initially generated 181 barriers, 457 barrier-specific facilitators, and 20 general facilitators. The number of consolidated barriers (barrier-specific facilitators in parentheses) for each category were: 14 (61) for health and medical; 4 (23) for social and personal; 1 (3) for time, work, and lifestyle; and 1 (4) for environmental. There were 12 consolidated general facilitators. The consolidated items with ≥ 1/3 of participants’ ratings ≥ 8 were: 15 barriers, 69 barrier-specific facilitators, and 9 general facilitators.
Conclusions People with SSc reported many barriers related to health and medical aspects of SSc and several barriers in other categories. They reported facilitators to remain physically active despite the barriers.
Implications for Rehabilitation
People with scleroderma experience difficulty being physically active due to the diverse and often severe manifestations of the disease, including involvement of the skin, musculoskeletal system, and internal organs.
In addition to regular care of scleroderma-related symptoms, patients overcome many exercise challenges by selecting physical activities that are comfortable for them, adjusting the intensity and duration of activities, adapting activities, and using adapted equipment or other materials to reduce discomfort.
Rehabilitation professionals should help people with scleroderma to tailor activity options to their capacity and needs when providing care and advice to promote physical activity.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by a Canadian Institutes of Health Research - Strategy for Patient-Oriented Research Grant (PI Shrier) with partner funding from the Scleroderma Society of Ontario. Mr. Harb was supported by a CIHR Canada Graduate Scholarship-Master's award. Ms. Rice was supported by a Vanier Graduate Scholarship. Dr. Thombs was supported by a Fonds de Recherche du Quebec - Sante researcher salary award.
Author Declarations
All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.
Not Applicable
I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.
Not Applicable
Footnotes
Sami Harb, Jewish General Hospital; 4333 Côte-Sainte-Catherine Road; Montreal, Quebec, Canada; H3T 1E4; Telephone: (514) 340-8222 ext. 26812; Email: sami.harb2{at}mail.mcgill.ca.
Julie Cumin, Jewish General Hospital; 4333 Côte-Sainte-Catherine Road; Montreal, Quebec, Canada; H3T 1E4; Telephone: (514) 340-8222 ext. 26812; Email: juliecumin{at}gmail.com.
Danielle B. Rice, Jewish General Hospital; 4333 Côte-Sainte-Catherine Road; Montreal, Quebec, Canada; H3T 1E4; Telephone: (514) 340-8222 ext. 26812; Email: danielle.rice{at}mail.mcgill.ca.
Sandra Peláez, Jewish General Hospital; 4333 Côte-Sainte-Catherine Road; Montreal, Quebec, Canada; H3T 1E4; Telephone: (514) 340-8222 ext. 26812; Email: sandra.pelaez{at}mail.mcgill.ca.
Marie Hudson, Jewish General Hospital; 3755 Côte-Sainte-Catherine Road; Montreal, Quebec, Canada; H3T 1E2; Telephone: (514) 340-8222 ext. 3476; Email: marie.hudson{at}mcgill.ca.
Susan J. Bartlett, McGill University; 687 Avenue Des Pins Ouest; Montreal, Quebec, Canada; H3A 1A1; Telephone: (514) 843-1465; Email: susan.bartlett{at}mcgill.ca.
Alexandra Roren, Hôpital Cochin; 27 Rue Du Faubourg Saint-Jacques; Paris, France; 75014; Telephone: 0158411371; Email: alexandra.roren{at}aphp.fr.
Daniel E. Furst, University of California, Los Angeles; 10833 Le Conte Avenue; Los Angeles, California, USA; 90095; Telephone: (310) 297-9221; Email: dan{at}furst.us.com.
Tracy M. Frech, University of Utah; 30 North 1900 East; Salt Lake City, Utah, USA; 84108; Telephone: (801) 581-4334; Email: tracy.frech{at}hsc.utah.edu.
Christelle Nguyen, Hôpital Cochin; 27 Rue Du Faubourg Saint-Jacques; Paris, France; 75014; Telephone: 33158412945; Email: christelle.nguyen2{at}aphp.fr.
Warren R. Nielson, Lawson Health Research Institute; 750 Base Line Road East; London, Ontario, Canada; N6C 2R5; Telephone: (519) 646-6100; Email: warren.nielson{at}rogers.com.
Brett D. Thombs, Jewish General Hospital; 4333 Côte-Sainte-Catherine Road; Montreal, Quebec, Canada; H3T 1E4; Telephone: (514) 340-8222 ext. 25112; Email: brett.thombs{at}mcgill.ca.
Ian Shrier, Jewish General Hospital; 3755 Côte-Sainte-Catherine Road; Montreal, Quebec, Canada; H3T 1E2; Telephone: (514) 340-8222 ext. 27563; Email: ian.shrier{at}mcgill.ca.
Data Availability
No additional data are available.
